TTI Q1 2026 Earnings Strong EPS Beat Drives Positive Stock Movement Compass Therapeutics Q1 2026 Earnings Narrowerthanexpected Loss Fuels Investor Optimism FATE Q1 2026 Earnings Narrows Loss Per Share Stock Rises on Improved Bottom Line Upstream Bio UPB Q1 2026 Earnings NarrowerThanExpected Loss Amid No Revenue Stock Edges Lower Telomir Pharmaceuticals Inc TELO Q4 2025 Earnings Wider Than Expected Loss Highlights PreRevenue Challenges GHC Q1 2026 Earnings Strong Earnings Beat Driven by Operational Efficiency